Open access · US-GOV
via ClinicalTrials.gov Clinical trial
An Observational Epidemiological Study on Evaluation of Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease in Clinical Practice
Authors not listed
Janssen-Cilag, S.A. · 2008
Abstract
The purpose of this study is to evaluate sleep quality in patients with mild to moderate Alzheimer's disease treated with anticholinesterase drugs in clinical practice.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Anonymous. (2008). An Observational Epidemiological Study on Evaluation of Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease in Clinical Practice. <em>Janssen-Cilag, S.A.</em>. https://clinicaltrials.gov/study/NCT01478204
Vancouver
Anonymous. An Observational Epidemiological Study on Evaluation of Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease in Clinical Practice. Janssen-Cilag, S.A.. 2008.
BibTeX
@misc{anon2008AnObse,
title = {An Observational Epidemiological Study on Evaluation of Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease in Clinical Practice},
author = {Anonymous},
journal = {Janssen-Cilag, S.A.},
year = {2008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Istituto Nazionale di Ricovero e Cura per Anziani 2020
Open access · US-GOV
ReportAge-COVID Project: Clinical and Biological Predictors of COVID-19 Disease in Older Patients
Memory Pharmaceuticals 2005
Open access · US-GOV
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of MEM 1003 in Patients With Mild to Moderate Alzheimer's Disease
Chang Gung Memorial Hospital 2019
Open access · US-GOV
Grounding the Body Improves Sleep Quality in Patients With Mild Alzheimer's Disease
Beijing Friendship Hospital 2015
Open access · US-GOV
Monetary Cost of Alzheimer's Disease in China: Study Protocol for a Cluster Randomized Observational Study
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2020
Open access · US-GOV
A Phase 3, Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Sodium Oligomannate (GV-971) in Treatment of Mild to Moderate Alzheimer's Disease (GREEN MEMORY: GREen Valley 971 EvaluatioN Memory)
Free Radical Biology and Medicine 1997
Citation only